Built In honors Cohere in its esteemed 2025 Best Places to Work awards.

In the post-COVID world, VCs say it’s not as easy to get excited about investing in digital health. Deal activity in healthcare IT was relatively flat in Q1 2024 at 74 total deals, valued at about $1 billion total, up only 3% from the year-ago quarter, according to PitchBook data. Still, promising startups have grabbed investors’ attention this year. TechCrunch spoke with about a dozen healthcare VCs about the companies they think have the most promising future. While recently formed AI-driven startups that are solving staggering administrative challenges in the U.S. healthcare system dominated their recommendations, they also mentioned several slightly older, non-AI-focused businesses.We narrowed their suggestions to the list of names that more than one VC mentioned, which came in at an even 10 companies. VCs discussed with us the companies that were both in their portfolios and not.AbridgeWhat it does: Uses AI to automate medical records based on conversations between doctors and patients.Founded in 2018 by Shiv Rao, a practicing cardiologist, Abridge is an early entrant into the medical note-taking space and one that has secured integration with the all-powerful Epic Systems health records software. Why it’s promising: The Pittsburgh-based startup generates excitement among investors and hospital systems eager to free up physicians’ time spent on note-taking

Humana Expands Use of Cohere Health’s Prior Authorization Platform. by Syed Hamza Sohail 04/23/2024 Leave a Comment. What You Should Know:–              Cohere Health, a recognized leader in clinical intelligence and prior authorization automation, announced that Humana Inc. (NYSE: HUM) will expand its use of Cohere’s prior authorization platform for diagnostic imaging and sleep services. –              In January 2021, Cohere and Humana began a pilot program in 12 states to improve the prior authorization process for musculoskeletal (MSK) services.Transformative Prior Authorization Solutions: Cohere’s Nationwide Impact on Healthcare Access and Provider SatisfactionThe program effectively decreased turnaround times for prior authorization approvals, boosted provider satisfaction, and improved care delivery for MSK services. This success led to expansion across all 50 states in 2022. In January 2023, Cohere’s solutions were rolled out nationwide, encompassing cardiovascular and surgical services.Cohere’s prior authorization platform expedites the approval process for providers and patients. Its unique combination of real-time analytics and evidence-based clinical intelligence reduces denial rates and facilitates quicker patient access to care.Annually, Cohere handles 5.5 million prior authorizations, benefiting over 15 million health plan members and 420,000 healthcare providers nationwide.“We’re pleased Humana will be utilizing our diagnostic imaging and sleep solutions, further strengthening our strategic and ongoing partnership,” said Siva Namasivayam, Chief Executive Officer of Cohere Health